110 related articles for article (PubMed ID: 8360025)
1. Anterior chamber-associated immune deviation elicited via primate eyes.
Eichhorn M; Horneber M; Streilein JW; Lutjen-Drecoll E
Invest Ophthalmol Vis Sci; 1993 Sep; 34(10):2926-30. PubMed ID: 8360025
[TBL] [Abstract][Full Text] [Related]
2. Analysis of immune deviation elicited by antigens injected into the subretinal space.
Wenkel H; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1823-34. PubMed ID: 9727405
[TBL] [Abstract][Full Text] [Related]
3. Anterior chamber-associated immune deviation induced by soluble antigens.
Mizuno K; Clark AF; Streilein JW
Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1112-9. PubMed ID: 2732026
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1 receptor antagonist therapy and induction of anterior chamber-associated immune deviation-type tolerance after corneal transplantation.
Yamada J; Zhu SN; Streilein JW; Dana MR
Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4203-8. PubMed ID: 11095616
[TBL] [Abstract][Full Text] [Related]
5. Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviation.
Yokoi H; Streilein JW
Ocul Immunol Inflamm; 2004 Jun; 12(2):101-14. PubMed ID: 15512980
[TBL] [Abstract][Full Text] [Related]
6. Blood-borne signals that induce anterior chamber-associated immune deviation after intracameral injection of antigen.
Streilein JW; Okamoto S; Hara Y; Kosiewicz M; Ksander B
Invest Ophthalmol Vis Sci; 1997 Oct; 38(11):2245-54. PubMed ID: 9344347
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-1 receptor antagonist suppresses Langerhans cell activity and promotes ocular immune privilege.
Dana MR; Dai R; Zhu S; Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):70-7. PubMed ID: 9430547
[TBL] [Abstract][Full Text] [Related]
8. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
9. Immune privilege is extended, then withdrawn, from allogeneic tumor cell grafts placed in the subretinal space.
Wenkel H; Chen PW; Ksander BR; Streilein JW
Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3202-8. PubMed ID: 10586943
[TBL] [Abstract][Full Text] [Related]
10. Studies on the induction of anterior chamber-associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta.
Wilbanks GA; Mammolenti M; Streilein JW
Eur J Immunol; 1992 Jan; 22(1):165-73. PubMed ID: 1530916
[TBL] [Abstract][Full Text] [Related]
11. Intracameral injection of antigen potentiates the production of antigen-specific T cell proteins in serum after the induction of delayed-type hypersensitivity.
Hadjikouti CA; Wang Y; O'Rourke J; Cone RE
Invest Ophthalmol Vis Sci; 1995 Jun; 36(7):1470-6. PubMed ID: 7775125
[TBL] [Abstract][Full Text] [Related]
12. Induction of anterior chamber-associated immune deviation by corneal allografts placed in the anterior chamber.
Yamada J; Streilein JW
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2833-43. PubMed ID: 9418737
[TBL] [Abstract][Full Text] [Related]
13. Loss and restoration of immune privilege in eyes with corneal neovascularization.
Dana MR; Streilein JW
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2485-94. PubMed ID: 8933765
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1 abrogates anterior chamber-associated immune deviation.
Benson JL; Niederkorn JY
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):2123-8. PubMed ID: 1698740
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclosporine on anterior chamber-associated immune deviation with retinal transplantation.
Ishioka M; Okamoto S; Streilein JW; Jiang LQ
Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2152-60. PubMed ID: 9331279
[TBL] [Abstract][Full Text] [Related]
16. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFbeta2-treated antigen presenting cells.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1410-21. PubMed ID: 10798657
[TBL] [Abstract][Full Text] [Related]
17. Loss of anterior chamber-associated immune deviation during normal pregnancy in primates.
Li Z; Peng G; Li C
Yan Ke Xue Bao; 1999 Mar; 15(1):41-5. PubMed ID: 12579661
[TBL] [Abstract][Full Text] [Related]
18. Induction of eye-derived tolerance does not depend on naturally occurring CD4+CD25+ T regulatory cells.
Keino H; Takeuchi M; Kezuka T; Hattori T; Usui M; Taguchi O; Streilein JW; Stein-Streilein J
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1047-55. PubMed ID: 16505040
[TBL] [Abstract][Full Text] [Related]
19. Anterior chamber inoculation of splenocytes without Fas/Fas-ligand interaction primes for a delayed-type hypersensitivity response rather than inducing anterior chamber-associated immune deviation.
Kawashima H; Yamagami S; Tsuru T; Gregerson DS
Eur J Immunol; 1997 Oct; 27(10):2490-4. PubMed ID: 9368601
[TBL] [Abstract][Full Text] [Related]
20. Studies on the induction of anterior chamber-associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood.
Wilbanks GA; Streilein JW
J Immunol; 1991 Apr; 146(8):2610-7. PubMed ID: 1707912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
